CVRx, Inc.
General ticker "CVRX" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $201.9M (TTM average)
CVRx, Inc. does not follow the US Stock Market performance with the rate: -34.1%.
Estimated limits based on current volatility of 2.0%: low 2.91$, high 3.15$
Factors to consider:
- Total employees count: 223 (+8.3%) as of 2025
- US accounted for 92.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Manufacturing disruptions, Supply chain disruptions, Regulatory and compliance, Clinical trial failure, Inability to raise capital
- Current price 30.8% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [4.44$, 11.02$]
- 2026-12-31 to 2027-12-31 estimated range: [3.85$, 9.86$]
Financial Metrics affecting the CVRX estimates:
- Negative: with PPE of -3.6 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -20.72 <= 0.28
- Positive: 18.97 < Shareholder equity ratio, % of 37.53 <= 42.26
- Positive: Inventory ratio change, % of -1.37 <= -0.75
- Positive: Investing cash flow per share per price, % of -0.30 > -0.64
- Positive: Interest expense per share per price, % of 3.01 <= 3.34
- Negative: negative Net income
Short-term CVRX quotes
Long-term CVRX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $39.30MM | $51.29MM | $56.65MM |
| Operating Expenses | $82.40MM | $110.78MM | $107.92MM |
| Operating Income | $-43.10MM | $-59.49MM | $-51.27MM |
| Non-Operating Income | $2.05MM | $-0.42MM | $-2.06MM |
| Interest Expense | $1.80MM | $4.40MM | $5.83MM |
| R&D Expense | $11.63MM | $11.13MM | $11.13MM |
| Income(Loss) | $-41.05MM | $-59.91MM | $-53.32MM |
| Taxes | $0.15MM | $0.06MM | $-0.02MM |
| Net Income(Loss)* | $-41.20MM | $-59.97MM | $-53.31MM |
| Stockholders Equity | $75.95MM | $71.06MM | $39.32MM |
| Inventory | $10.98MM | $12.11MM | $12.21MM |
| Assets | $115.23MM | $133.41MM | $104.79MM |
| Operating Cash Flow | $-39.02MM | $-39.14MM | $-40.17MM |
| Capital expenditure | $0.59MM | $1.36MM | $0.58MM |
| Investing Cash Flow | $-0.59MM | $-1.36MM | $-0.58MM |
| Financing Cash Flow | $23.98MM | $55.87MM | $10.52MM |
| Earnings Per Share** | $-1.99 | $-2.65 | $-2.04 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.